Review of outbreaks and barriers to MMR vaccination coverage among hard to reach populations in European countries
In recent years, substantial progress had been made towards eliminating measles, mumps and rubella in Europe. Measles vaccine coverage is on the rise and measles cases decreasing in many countries. However, there have still been several large outbreaks of measles, mumps and rubella reported in European countries.
Migrant health: Sexual transmission of HIV within migrant groups in the EU/EEA and implications for effective interventions
This report presents the published evidence of sexual transmission of HIV among populations from countries with generalised HIV epidemics in the EU/EEA.
Thematic Report: Migrants - Monitoring implementation of the Dublin Declaration on Partnership to Fight HIV/AIDS in Europe and Central Asia: 2012 progress
Health inequalities, the financial crisis, and infectious disease in Europe
This report summarises the importance of addressing health inequalities by identifying key areas for attention from health professionals and policy makers. Presenting key findings from studies on the subject, it makes the case that socio-economic determinants can have a substantial impact on infectious disease control in Europe.
A comprehensive approach to HIV/STI prevention in the context of sexual health in the EU/EEA
This report highlights the benefits of a comprehensive approach to disease prevention, integrating HIV and STI control programming in Europe into broader public health strategies.
Social determinants and risk factors in tuberculosis surveillance in the EU/EEA
The objective of this report is to provide countries with advice on what social determinant and risk factor variables to collect and what definitions to use, and to propose information to be collected at the national and European level.
Hepatitis B and C in the EU neighbourhood: prevalence, burden of disease and screening policies
This literature review answers a series of questions on the prevalence of chronic HBV and HCV infection in the general EU population, the number of individuals with chronic HBV or HCV infection, and current national practices for screening for chronic HBV and HCV infection, all with the overarching goal of promoting national and European policies on the secondary prevention of these two diseases.